PATENT CLAIM ANALYSIS

Application Number: 16213052
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "183000"]

Abstract:
Described herein are compositions and compounds having one or more aziridinyl groups, and methods of making the same. The compounds can also have one or more nitrogen atoms that each can be positively charged. The composition and compounds can inactivate one or more nucleic acid molecules (e.g. a DNA and/or a RNA from a pathogen) in a sample. The sample can comprise a blood or blood product (e.g., donated blood). The compositions and compounds can inactivate any nucleic acid present in a blood or blood product, thereby making the blood or blood product safe for use (e.g., in a transfusion).

Claim (Index 3):
The compound of  claim 2 , wherein each n is, independently for each occurrence, 2, 3 or 4.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 98.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15036675', '14889215', '15395221', '14918022', '13017242']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593155262291443
- 35 USC 102 Novelty (BERT): 0.5265299482493099
- Combined Prediction Score: 0.736036968431161
- Mean Citation Score: 202.27912
- Max Citation Score: 323.01727
- Similarity Product: 211.967222213304

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test